[The effect of 3-(5)-methyl-5-(3)-pyrazol-carbonic acid (MPK) on alloxan diabetic lipaemia of rats].
D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy*; D005227:Fatty Acids / Q000097:blood*; D006949:Hyperlipidemias / Q000188:drug therapy*; D051381:Rats; D013501:Surface-Active Agents; D014280:Triglycerides / Q000097:blood*
D005227:Fatty Acids; D013501:Surface-Active Agents; D014280:Triglycerides
3-(5)-metil-5-(3)-pirazol-karbonsav (MPK) patkányok alloxán-diabeteses lipaemiájára gyakorolt hatása.